ONCOSEC MEDICAL Inc Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q1 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ONCOSEC MEDICAL Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q1 2023.
  • ONCOSEC MEDICAL Inc Entity Common Stock, Shares Outstanding for the quarter ending March 13, 2023 was 2.97M shares, a 92.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 2.97M -36.4M -92.4% Mar 13, 2023 10-Q 2023-03-14
Q4 2022 2.97M -36.4M -92.4% Dec 15, 2022 10-Q 2022-12-15
Q3 2022 39.4M +194K +0.49% Oct 31, 2022 10-K 2022-10-31
Q2 2022 39.4M +180K +0.46% Jun 14, 2022 10-Q 2022-06-14
Q1 2022 39.4M +2.19M +5.9% Mar 15, 2022 10-Q 2022-03-15
Q4 2021 39.3M +11.3M +40.5% Dec 15, 2021 10-Q 2021-12-15
Q3 2021 39.2M +11.5M +41.6% Oct 29, 2021 10-K 2021-10-29
Q2 2021 39.2M +16.2M +70.1% Jun 11, 2021 10-Q 2021-06-11
Q1 2021 37.2M +14.4M +63.3% Mar 12, 2021 10-Q 2021-03-15
Q4 2020 28M +17.3M +161% Dec 11, 2020 10-Q 2020-12-11
Q3 2020 27.7M +17M +159% Oct 28, 2020 10-K 2020-10-28
Q2 2020 23M +12.4M +117% Jun 12, 2020 10-Q 2020-06-15
Q1 2020 22.8M -42M -64.9% Mar 13, 2020 10-Q 2020-03-16
Q4 2019 10.7M -53.8M -83.4% Dec 13, 2019 10-Q 2019-12-13
Q3 2019 10.7M -48.5M -82% Oct 25, 2019 10-K 2019-10-28
Q2 2019 10.6M -41.7M -79.7% Jun 14, 2019 10-Q 2019-06-14
Q1 2019 64.8M +13.3M +25.9% Mar 8, 2019 10-Q 2019-03-08
Q4 2018 64.5M +29M +81.6% Dec 14, 2018 10-Q 2018-12-14
Q3 2018 59.2M +37.1M +168% Oct 19, 2018 10-K 2018-10-19
Q2 2018 52.3M +31.2M +147% Jun 6, 2018 10-Q 2018-06-13
Q1 2018 51.5M +30.6M +147% Mar 7, 2018 10-Q 2018-03-09
Q4 2017 35.5M +15.8M +80% Dec 5, 2017 10-Q 2017-12-07
Q3 2017 22.1M +2.94M +15.3% Oct 10, 2017 10-K 2017-10-25
Q2 2017 21.2M +3.53M +20% May 31, 2017 10-Q 2017-06-01
Q1 2017 20.9M +3.9M +23% Mar 13, 2017 10-Q 2017-03-16
Q4 2016 19.7M +2.76M +16.3% Dec 1, 2016 10-Q 2016-12-08
Q3 2016 19.2M +4.33M +29.2% Oct 7, 2016 10-K 2016-10-13
Q2 2016 17.6M +5.28M +42.8% Jun 1, 2016 10-Q 2016-06-09
Q1 2016 17M -230M -93.1% Mar 4, 2016 10-Q 2016-03-08
Q4 2015 17M -230M -93.1% Dec 1, 2015 10-Q 2015-12-08
Q3 2015 14.8M -230M -93.9% Oct 9, 2015 10-K 2015-10-14
Q2 2015 12.4M -232M -94.9% Jun 5, 2015 10-Q 2015-06-09
Q1 2015 247M +34.8M +16.4% Mar 6, 2015 10-Q 2015-03-12
Q4 2014 247M +75.8M +44.3% Dec 2, 2014 10-Q 2014-12-08
Q3 2014 245M +73.8M +43.2% Oct 1, 2014 10-K 2014-10-10
Q2 2014 244M +126M +107% Jun 9, 2014 10-Q 2014-06-13
Q1 2014 212M +94.3M +80.1% Mar 12, 2014 10-Q 2014-03-14
Q4 2013 171M +82.4M +93.2% Dec 13, 2013 10-Q 2013-12-16
Q3 2013 171M +83M +94.5% Sep 27, 2013 10-K 2013-09-27
Q2 2013 118M +30.2M +34.3% Jun 14, 2013 10-Q 2013-06-14
Q1 2013 118M +61M +107% Mar 15, 2013 10-Q 2013-03-15
Q4 2012 88.4M +31.6M +55.5% Dec 17, 2012 10-Q 2012-12-17
Q3 2012 87.9M Oct 12, 2012 10-K 2012-10-15
Q2 2012 87.9M Jun 14, 2012 10-Q 2012-06-14
Q1 2012 56.9M Mar 15, 2012 10-Q 2012-03-16
Q4 2011 56.9M Dec 14, 2011 10-Q 2011-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.